You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

Article info

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

Authors

  • Oliver Klein Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Victoria, AustraliaOlivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Damien Kee Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Bo Gao Blacktown Hospital and the University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ben Markman Department of Medical Oncology, Monash Health, Melbourne, Victoria, AustraliaMonash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jessica da Gama Duarte Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, AustraliaSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Luke Quigley Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, AustraliaSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Louise Jackett Department of Anatomical Pathology, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Richelle Linklater Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Andrew Strickland Department of Medical Oncology, Monash Health, Melbourne, Victoria, AustraliaMonash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Clare Scott Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Linda Mileshkin Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jodie Palmer Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, AustraliaSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Matteo Carlino Blacktown Hospital and the University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Andreas Behren Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, AustraliaSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, AustraliaDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jonathan Cebon Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Victoria, AustraliaOlivia Newton-John Cancer Research Institute, Melbourne, Victoria, AustraliaSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, AustraliaDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles

Citation

Klein O, Kee D, Gao B, et al
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
Journal for ImmunoTherapy of Cancer 2021;9:e003156. doi: 10.1136/jitc-2021-003156
Online issue publication 
May 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.